Detalhe da pesquisa
1.
Integrative clinical genomics of advanced prostate cancer.
Cell
; 161(5): 1215-1228, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26000489
2.
Integrative Clinical Genomics of Advanced Prostate Cancer.
Cell
; 162(2): 454, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843286
3.
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.
J Urol
; 209(1): 121-130, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317715
4.
Integrative clinical genomics of metastatic cancer.
Nature
; 548(7667): 297-303, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783718
5.
Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor.
J Oncol Pharm Pract
; 29(4): 912-916, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959716
6.
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Br J Cancer
; 125(1): 28-37, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941878
7.
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Int J Mol Sci
; 23(1)2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008431
8.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767
9.
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
Br J Cancer
; 123(11): 1590-1598, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913286
10.
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Invest New Drugs
; 38(5): 1421-1429, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984451
11.
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
Cancer
; 125(7): 1124-1132, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30624766
12.
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors.
Invest New Drugs
; 37(3): 461-472, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30229512
13.
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors.
Invest New Drugs
; 37(4): 722-730, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591982
14.
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
Invest New Drugs
; 37(2): 297-306, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132271
15.
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(12): 1529-1554, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805523
16.
Towards a 3D GeSbTe phase change memory with integrated selector by non-aqueous electrodeposition.
Faraday Discuss
; 213(0): 339-355, 2019 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411749
17.
Probing Excitons, Trions, and Dark Excitons in Monolayer WS2 Using Resonance Raman Spectroscopy.
Nano Lett
; 18(2): 1428-1434, 2018 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297693
18.
Exploration of the Smallest Diameter Tin Nanowires Achievable with Electrodeposition: Sub 7 nm Sn Nanowires Produced by Electrodeposition from a Supercritical Fluid.
Nano Lett
; 18(2): 941-947, 2018 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29356551
19.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314841
20.
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.
Oncologist
; 21(4): 402-3, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26984445